Bidirectional Effects of the Brain-Gut Axis in Inflammatory Bowel Disease
Investigators analyzed effects of the gut-brain axis on adverse disease outcomes and psychological health in patients with IBD.
Investigators analyzed effects of the gut-brain axis on adverse disease outcomes and psychological health in patients with IBD.
Investigators assessed the effects of 300 mg daily thiamine on maintaining levels of fatigue in patients with IBD previously receiving high-dose thiamine.
Investigators examined the incidence of and risk factors for venous thromboembolism in pediatric patients with IBD compared with the general pediatric population.
Researchers assessed the efficacy and safety of a novel form of bioenhanced curcumin for treatment of mild to moderately active ulcerative colitis.
Clinicians summarized the current research and clarified widespread misinformation on celiac disease.
Investigators assessed trends in corticosteroid use in patients with IBD over a period of 20 years.
Reviewing a patient’s potential risk for osteoporosis should be a routine part of each visit for patients with IBD.
Investigators examined the effects of spirulina on anthropometric parameters, blood pressure, and quality of life measures in patients with ulcerative colitis.
Investigators aimed to characterize the systemic, preclinical inflammatory immune response of UC using a comprehensive set of proteins.
Due to the relatively high relapse rate and need for additional therapies, current research is being done on the use of Vedolizumab for the treatment of microscopic colitis.